Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized,Double Blind, Parallel Group, Placebo Controlled Dose Ranging Study to Assess the Analgesic Efficacy, Tolerability, Safety and Pharmacokinetic/Pharmacodynamic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02199678

Organisation Name: Lotus Clinical Research, LLC

Overal Status: Completed

Start Date: July 2014

Last Update: November 21, 2014

Lead Sponsor: Lotus Clinical Research, LLC

Brief Summary: This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafer in adult subjects who experience post operative pain after undergoing third molar extraction.

Conditions:
  • Pain


Total execution time in seconds: 0.20206689834595